Relationship between Acute Phase Proteins and Serum Fatty Acid Composition in Morbidly Obese Patients

Table 4

Correlations between the relative contents of serum fatty acids and acute phase proteins in morbidly obese subjects studied (𝑛=21).

Fatty acids	ORM	CRP	Albumin	CRP/; Albumin
SFA
C12:0 (lauric acid)^a	−0.48^∗	−0.44^∗	0.07	−0.38
C14:0 (myristic acid)^a	−0.26	−0.29	−0.21	−0.19
C16:0 (palmitic acid)^a	0.20	0.10	−0.20	0.14
C17:0 (margaric acid)^b	−0.09	−0.57^∗	0.58^∗	−0.59^∗
C18:0 (stearic acid)^a	−0.19	0.03	0.11	0.03
MUFA
C16:1 n-7 (palmitoleic acid)^a	−0.10	0.24	0.08	0.18
C18:1 n-9 (oleic acid)^a	0.14	0.23	−0.07	0.19
n-3 PUFA
C20:5 n-3 (EPA)^b	−0.46^∗	−0.29	0.51^∗	−0.33
C22:6 n-3 (DHA)^a	−0.07	−0.14	0.06	−0.12
n-6 PUFA
C18:2 n-6 (linoleic acid)^b	0.19	0.41	−0.41	0.39
C20:4 n-6 (AA)^a	0.46^∗	0.01	−0.11	0.01
n-6/n-3^a	0.46^∗	0.26	−0.24	0.25
AA/EPA^a	0.59^∗	0.22	−0.32	0.23
PUFA/SFA^a	0.42	0.22	−0.12	0.20

AA: arachidonic acid; CRP: C-reactive Protein; EPA: eicosapentaenoic acid; DHA: docosahexaenoic acid; ORM: orosomucoid; MUFA: monounsaturated fatty acids; PUFA: Polyunsaturated fatty acids; SFA: saturated fatty acids.
^∗𝑃<0.05, aPearson’s correlation, bSpearman’s correlation.